Stay updated on Efgartigimod Safety & Efficacy in pSS Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.

Latest updates to the Efgartigimod Safety & Efficacy in pSS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error, replacing the detailed study content with an error page. As a result, the trial's title, conditions, locations, documents, and other structured data become inaccessible in this view.SummaryDifference18%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page shows an updated Revision tag from v3.6.5 to v3.6.6. This appears to be a minor platform update and does not change the study details or how users interact with the page.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision has been updated to v3.6.5, replacing v3.6.4. This reflects an updated document state rather than changes to the study details or overall content.SummaryDifference0.0%

- Check69 days agoChange DetectedA publication citation in the Publications section was updated to reflect a 2026 July version with a DOI, replacing the earlier print/online-ahead-of-print entry. This is a bibliographic update rather than a change to study data or conduct.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a small update to the study record.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page now displays revision v3.6.2, replacing v3.6.0, indicating a small maintenance update to the page's version tag without altering study content.SummaryDifference0.1%

Stay in the know with updates to Efgartigimod Safety & Efficacy in pSS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod Safety & Efficacy in pSS Clinical Trial page.